Just over 24 hours after an FDA advisory panel recommended emergency use of Pfizer and BioNTech’s COVID-19 vaccine, the agency followed through, authorizing the first coronavirus pandemic shot for emergency use in the U.S.
The FDA...
Late day Thursday, a government advisory panel gave their nods for the use of Pfizer’s COVID-19 vaccine, allowing for the Food and Drug Administration (FDA) to grant the approval for the vaccine.
In a 17-4...
In a published study, in EBio Medicine, researchers at Arizona-based biotech, Aqualung Therapeutics may have identified a novel biomarker that alone, or potentially combined with Prostate-specific antigen (PSA), may determine men who are at higher risk of...
According to new research published today in the American Heart Association's flagship journal Circulation, women face a 20% increased risk of developing heart failure or dying within five years after their first severe heart attack compared with...
Moderna today announced that the primary efficacy analysis of their Phase 3 study of their vaccine candidate, mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The data analysis indicates a...
A third COVID-19 vaccine, this one from AstraZeneca, reported Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90% effective in preventing disease.
The results are based on...
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients with positive results of direct SARS-CoV-2...
Pfizer Inc. and its German partner, BioNTech SE will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable...
In a press release issued today, Pfizer said that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying — the last data needed to...
Moderna said its experimental coronavirus vaccine was nearly 95 percent effective in a pivotal study. The NIH-appointed Data Safety Monitoring Board (DSMB) informed Moderna that the trial has met the statistical criteria pre-specified in the study protocol for...
Quicken Inc., maker of America's best-selling personal finance software, today shared findings from a survey that explored Americans' financial outlook amid the...